Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times

J.P. Morgan stated last month that it believes there is a 60% chance of a recession in 2025 due to trade wars and tariffs. The raging bull market that started at the beginning of 2023 is in jeopardy. No one knows precisely when the bulls will get tired and the bears will come out of hibernation. Sometimes, it's a black swan event that is impossible to predict. Other times, it's a simple matter of exhaustion and valuations that go too far.The recent market downturn is an excellent example. After the election, the general consensus was that the new administration would be positive for the stock market, and the major indexes rose immediately after Election Day. The continuation of the bull market hasn't come to fruition. Trade wars, tariffs, and uncertainty spooked the major indexes into correction territory. And, despite the recent rebound, many believe there is more pain to come. Time will tell.Pharmaceutical stocks often outperform during market downturns because they pay dividends and their products are mostly necessities. AbbVie (NYSE: ABBV) is one of the best. It outperformed the Invesco Nasdaq Trust by 57% when tech crashed in 2022, as you can see below.Continue reading

May 11, 2025 - 14:33
 0
Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times

J.P. Morgan stated last month that it believes there is a 60% chance of a recession in 2025 due to trade wars and tariffs. The raging bull market that started at the beginning of 2023 is in jeopardy. No one knows precisely when the bulls will get tired and the bears will come out of hibernation. Sometimes, it's a black swan event that is impossible to predict. Other times, it's a simple matter of exhaustion and valuations that go too far.

The recent market downturn is an excellent example. After the election, the general consensus was that the new administration would be positive for the stock market, and the major indexes rose immediately after Election Day. The continuation of the bull market hasn't come to fruition. Trade wars, tariffs, and uncertainty spooked the major indexes into correction territory. And, despite the recent rebound, many believe there is more pain to come. Time will tell.

Pharmaceutical stocks often outperform during market downturns because they pay dividends and their products are mostly necessities. AbbVie (NYSE: ABBV) is one of the best. It outperformed the Invesco Nasdaq Trust by 57% when tech crashed in 2022, as you can see below.

Continue reading